购物车
- 全部删除
- 您的购物车当前为空
SHR-1701 是一种新型的双功能融合蛋白,由 PD-L1 的单克隆抗体与 TGFβ 受体 II 的细胞外结构域融合而成。SHR-1701 具有抗肿瘤活性,可用于实体瘤研究。
SHR-1701 是一种新型的双功能融合蛋白,由 PD-L1 的单克隆抗体与 TGFβ 受体 II 的细胞外结构域融合而成。SHR-1701 具有抗肿瘤活性,可用于实体瘤研究。
产品描述 | SHR-1701 is a novel bifunctional fusion protein composed of a mAb against programmed death ligand 1 (PD-L1) fused with the extracellular domain of TGFβ receptor II. SHR-1701 has antitumour activity and can be used in solid tumour research. |
别名 | Retlirafusp alfa |
CAS No. | 2891860-17-4 |
存储 | Shipping with blue ice. |
评论内容